Adaptive Biotechnologies Corporation (ADPT)
Nasdaq: ADPT · Biological Products, (No Diagnostic Substances) · Seattle, WA · filing with the SEC since 2009
The company now
Adaptive Biotechnologies Corporation is classed by the SEC under Biological Products, (No Diagnostic Substances) (industry code 2836), based in Seattle, WA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $277 million and a loss of $59 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.